Limit of Detection for Rapid Antigen Testing of the SARS-CoV-2 Omicron Variant

Sydney Stanley, Donald J. Hamel, Ian D. Wolf, Stefan Riedel, Sanjucta Dutta, Annie Cheng, James E. Kirby, Phyllis J. Kanki
doi: https://doi.org/10.1101/2022.01.28.22269968

Article Information

doi 
https://doi.org/10.1101/2022.01.28.22269968
History 
  • January 30, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Sydney Stanley1,
  2. Donald J. Hamel1,
  3. Ian D. Wolf1,
  4. Stefan Riedel2,3,
  5. Sanjucta Dutta2,
  6. Annie Cheng2,
  7. James E. Kirby*,#,2,3 and
  8. Phyllis J. Kanki*,#,1
  1. 1Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA
  2. 2Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
  3. 3Harvard Medical School, Boston, Massachusetts, USA
  1. ↵#Address for correspondence: Phyllis J. Kanki, DVM, PhD, 651 Huntington Avenue, FXB Building, Room 405B, Boston, Massachusetts 02115, 617.432.1267, pkanki{at}hsph.harvard.edu, James E. Kirby, MD, Beth Israel Deaconess Medical Center, 330 Brookline Avenue – YA309, Boston MA 02215, 617-667-3648, jekirby{at}bidmc.harvard.edu
Back to top
Posted January 30, 2022.
Download PDF
Data/Code
Email
Limit of Detection for Rapid Antigen Testing of the SARS-CoV-2 Omicron Variant
Sydney Stanley, Donald J. Hamel, Ian D. Wolf, Stefan Riedel, Sanjucta Dutta, Annie Cheng, James E. Kirby, Phyllis J. Kanki
medRxiv 2022.01.28.22269968; doi: https://doi.org/10.1101/2022.01.28.22269968
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area